Wulfran Cacheux

Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†

Eduardo Schiffer, Chantal Housset, Wulfran Cacheux et al. · Hepatology · 2005 · 336 citations · Full text

Medicine, Oncology, Pharmacology +17

Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth

Jonathan Lévy, Wulfran Cacheux, Medhi Ait Bara et al. · Nature Cell Biology · 2015 · 183 citations

Life Sciences, Cancer Biology, Immunology +17

Complex interplay between  -catenin signalling and Notch effectors in intestinal tumorigenesis

Grégory Peignon, Aurélie Durand, Wulfran Cacheux et al. · Gut · 2011 · 145 citations · Full text

Medicine, Molecular Biology, Oncology +17

Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut

Maïa Chanrion, Inna Kuperstein, Cédric Barrière et al. · Nature Communications · 2014 · 134 citations · Full text

Medicine, Cancer Biology, Oncology +17

Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues

Bertrand Brieau, Laëtitia Dahan, Yann De Rycke et al. · Cancer · 2015 · 122 citations

Medicine, Oncology, Chemotherapy +10